Dubroff: Museum of Ventura County deserves to be preserved

Just a year ago, the city of Ventura was celebrating its 150th anniversary with a lot of fanfare and one heck of a party. Now, with one of its iconic cultural institutions in need of help, city officials and Ventura County’s board of supervisors will have to weigh the long-term benefits of putting the Museum Read More →
Amgen asks FDA to consider new uses for Xgeva

Thousand Oaks-based biotech giant Amgen announced June 19 that the U.S. Food and Drug Administration has accepted a supplemental application for Xgeva (denosumab) that seeks to expand the currently approved indication for the prevention of fractures and other skeletal-related events in patients with bone metastases from solid tumors to include patients with multiple myeloma. “Multiple Read More →
Amgen to provide rebates for Repatha patients who have heart attack or stroke

Thousand Oaks-based Amgen announced on May 2 that it has reached a “first-of-its-kind contract” with health care company Harvard Pilgrim. The contract provides Harvard Pilgrim with a rebate for the cost of Repatha for any eligible patient who has a heart attack or stroke while on Repatha. “Amgen is committed to combating cardiovascular disease, one Read More →
Amgen revenues fall but profits increase

Thousand Oaks-based biotech giant Amgen’s total revenues decreased by 1 percent to $5.5 billion during the first quarter of 2017, compared to the same period a year ago, according to an earnings report April 26. The drop was related to the plunge in sales of Enbrel, its rheumatoid arthritis drug. Sales decreased 15 percent due Read More →